CoChat
Sign Up
Cited by 51

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Control of human -globin mRNA stability and its impact on beta-thalassemia phenotype

Peixeiro, I., Silva, A. L., Romao, L.·2011·Haematologica
DOI 10.3324/haematol.2010.039206
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3324/haematol.2010.039206

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 85

  1. Ross J. mRNA stability in mammalian cells. Microbiol Rev. 1995;59(3):423-50.
  2. Sachs AB, Sarnow P, Hentze MW. Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell. 1997;89(6): 831-8.
  3. Russell JE, Morales J, Liebhaber SA. The role of mRNA stability in the control of globin gene expression. Prog Nucleic Acid Res Mol Biol. 1997;57:249-87.
  4. Guhaniyogi J, Brewer G. Regulation of mRNA stability in mammalian cells. Gene. 2001;265(1-2):11-23.
  5. Tomecki R, Drazkowska K, Dziembowski A. Mechanisms of RNA degradation by the eukaryotic exosome. Chembiochem. 2010; 11(7):938-45.
  6. Li XA, Beebe DC. Messenger RNA stabiliza- tion in chicken lens development: a reexam- ination. Dev Biol. 1991;146(1):239-41.
  7. Hamalainen L, Oikarinen J, Kivirikko KI. Synthesis and degradation of type I procolla- gen mRNAs in cultured human skin fibrob- lasts and the effect of cortisol. J Biol Chem. 1985;260(2):720-5.
  8. Aviv H, Voloch Z, Bastos R, Levy S. Biosynthesis and stability of globin mRNA in cultured erythroleukemic Friend cells. Cell. 1976;8(4):495-503.
  9. Ross J, Sullivan TD. Half-lives of beta and gamma globin messenger RNAs and of pro- tein synthetic capacity in cultured human reticulocytes. Blood. 1985;66(5):1149-54.
  10. Jacobson A, Peltz SW. Interrelationships of the pathways of mRNA decay and transla- tion in eukaryotic cells. Annu Rev Biochem. 1996;65:693-739.
  11. Bastos RN, Aviv H. Theoretical analysis of a model for globin messenger RNA accumula- tion during erythropoiesis. J Mol Biol. 1977; 110(2):205-18.
  12. Bastos RN, Volloch Z, Aviv H. Messenger RNA population analysis during erythroid differentiation: a kinetical approach. J Mol Biol. 1977;110(2):191-203.
  13. Inacio A, Silva AL, Pinto J, Ji X, Morgado A, Almeida F, et al. Nonsense mutations in close proximity to the initiation codon fail to trigger full nonsense-mediated mRNA decay. J Biol Chem. 2004;279(31):32170-80.
  14. Clegg JB, Weatherall DJ, Milner PF. Haemoglobin Constant Spring--a chain ter- mination mutant? Nature. 1971;234(5328): 337-40.
  15. Waggoner SA, Liebhaber SA. Regulation of alpha-globin mRNA stability. Exp Biol Med (Maywood). 2003;228(4):387-95.
  16. Liebhaber SA, Kan YW. alpha-Thalassemia caused by an unstable alpha-globin mutant. J Clin Invest. 1983;71(3):461-6.
  17. Morales J, Russell JE, Liebhaber SA. Destabilization of human alpha-globin mRNA by translation anti-termination is controlled during erythroid differentiation and is paralleled by phased shortening of the poly(A) tail. J Biol Chem. 1997;272(10):6607- 13.
  18. Kiledjian M, Wang X, Liebhaber SA. Identification of two KH domain proteins in the alpha-globin mRNP stability complex. EMBO J. 1995;14(17):4357-64.
  19. Kong J, Ji X, Liebhaber SA. The KH-domain protein alpha CP has a direct role in mRNA stabilization independent of its cognate binding site. Mol Cell Biol. 2003;23(4):1125- 34.
  20. Wang Z, Kiledjian M. The poly(A)-binding protein and an mRNA stability protein joint- ly regulate an endoribonuclease activity. Mol Cell Biol. 2000;20(17):6334-41.
  21. Rodgers ND, Wang Z, Kiledjian M. Regulated alpha-globin mRNA decay is a cytoplasmic event proceeding through 3'-to- 5' exosome-dependent decapping. RNA. 2002;8(12):1526-37.
  22. Flatz G, Kinderlerer JL, Kilmartin JV, Lehmann H. Haemoglobin Tak: a variant with additional residues at the end of the beta-chains. Lancet. 1971;1(7702):732-3.
  23. Imai K, Lehmann H. The oxygen affinity of haemoglobin Tak, a variant with an elongat- ed beta chain. Biochim Biophys Acta. 1975;412(2):288-94.
  24. Tanphaichitr VS, Viprakasit V, Veerakul G, Sanpakit K, Tientadakul P. Homozygous hemoglobin Tak causes symptomatic sec- ondary polycythemia in a Thai boy. J Pediatr Hematol Oncol. 2003;25(3):261-5.
  25. Jankovic L, Dimovski AJ, Kollia P, Karageorga M, Loukopoulos D, Huisman TH. A C----G mutation at nt position 6 3' to the terminating codon may be the cause of a silent beta-thalassemia. Int J Hematol. 1991;54(4):289-93.
  26. Bilenoglu O, Basak AN, Russell JE. A 3'UTR mutation affects beta-globin expression without altering the stability of its fully processed mRNA. Br J Haematol. 2002;119 (4):1106-14.
  27. Cai SP, Eng B, Francombe WH, Olivieri NF, Kendall AG, Waye JS, et al. Two novel beta- thalassemia mutations in the 5' and 3' non- coding regions of the beta-globin gene. Blood. 1992;79(5):1342-6.
  28. Rund D, Filon D, Dowling C, Kazazian HH Jr, Rachmilewitz EA, Oppenheim A. Molecular studies of beta-thalassemia in Israel. Mutational analysis and expression studies. Ann NY Acad Sci. 1990;612:98-105.
  29. Ghanem N, Girodon E, Vidaud M, Martin J, Fanen P, Plassa F, et al. A comprehensive scanning method for rapid detection of beta- globin gene mutations and polymorphisms. Hum Mutat. 1992;1(3):229-39.
  30. Jankovic L, Efremov GD, Petkov G, Kattamis C, George E, Yang KG, et al. Two novel polyadenylation mutations leading to beta(+)-thalassemia. Br J Haematol. 1990;75 (1):122-6.
  31. Orkin SH, Cheng TC, Antonarakis SE, Kazazian HH Jr. Thalassemia due to a muta- tion in the cleavage-polyadenylation signal of the human beta-globin gene. EMBO J. 1985;4(2):453-6.
  32. Proudfoot NJ. Genetic dangers in poly(A) signals. EMBO Rep. 2001;2(10):891-2.
  33. Kabnick KS, Housman DE. Determinants that contribute to cytoplasmic stability of human c-fos and beta-globin mRNAs are located at several sites in each mRNA. Mol Cell Biol. 1988;8(8):3244-50.
  34. Weiss IM, Liebhaber SA. Erythroid cell-spe- cific mRNA stability elements in the alpha 2- globin 3' nontranslated region. Mol Cell Biol. 1995;15(5):2457-65.
  35. Russell JE, Liebhaber SA. The stability of human beta-globin mRNA is dependent on structural determinants positioned within its 3' untranslated region. Blood. 1996;87(12): 5314-23.
  36. Weiss IM, Liebhaber SA. Erythroid cell-spe- cific determinants of alpha-globin mRNA stability. Mol Cell Biol. 1994;14(12):8123-32.
  37. Sgourou A, Papachatzopoulou A, Psiouri L, Antoniou M, Zoumbos N, Gibbs R, et al. The beta-globin C-->G mutation at 6 bp 3' to the termination codon causes beta-thalas- saemia by decreasing the mRNA level. Br J Haematol. 2002;118(2):671-6.
  38. Yu J, Russell JE. Structural and functional analysis of an mRNP complex that mediates the high stability of human beta-globin mRNA. Mol Cell Biol. 2001;21(17):5879-88.
  39. Chen CY, Shyu AB. Rapid deadenylation triggered by a nonsense codon precedes decay of the RNA body in a mammalian cytoplasmic nonsense-mediated decay path- way. Mol Cell Biol. 2003;23(14):4805-13.
  40. Stolle CA, Benz EJ Jr. Cellular factor affecting the stability of beta-globin mRNA. Gene. 1988;62(1):65-74.
  41. Jiang Y, Xu XC, Russell JE. A Nucleolin- Binding 3' Untranslated Region Element Stabilizes b-Globin mRNA In Vivo. Mol Cell Biol. 2006;26(6):2419-29.
  42. Moore MJ. From birth to death: the complex lives of eukaryotic mRNAs. Science. 2005;309(5740):1514-8.
  43. Silva AL, Romao L. The mammalian non- sense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision? FEBS Lett. 2009;583(3):499- 505.
  44. Vasudevan S, Peltz SW, Wilusz CJ. Non-stop decay--a new mRNA surveillance pathway. Bioessays. 2002;24(9):785-8.
  45. Garneau NL, Wilusz J, Wilusz CJ. The high- ways and byways of mRNA decay. Nat Rev Mol Cell Biol. 2007;8(2):113-26.
  46. Stalder L, Muhlemann O. The meaning of nonsense. Trends Cell Biol. 2008;18(7):315- 21.
  47. Bhuvanagiri M, Schlitter AM, Hentze MW, Kulozik AE. NMD: RNA biology meets human genetic medicine. Biochem J. 2010;430(3):365-77.
  48. Kong J, Liebhaber SA. A cell type-restricted mRNA surveillance pathway triggered by ribosome extension into the 3' untranslated region. Nat Struct Mol Biol. 2007;14(7):670- 6.
  49. Voon HP, Vadolas J. Controlling alpha-glo- bin: a review of alpha-globin expression and its impact on beta-thalassemia. Haematologica. 2008;93(12):1868-76.
  50. Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE. Nonsense-mediated decay approaches the clinic. Nat Genet. 2004;36 (8):801-8.
  51. Kozak M. Pushing the limits of the scanning mechanism for initiation of translation. Gene. 2002;299(1-2):1-34.
  52. Conti E, Izaurralde E. Nonsense-mediated mRNA decay: molecular insights and mech- anistic variations across species. Curr Opin Cell Biol. 2005;17(3):316-25.
  53. Bhattacharya A, Czaplinski K, Trifillis P, He F, Jacobson A, Peltz SW. Characterization of the biochemical properties of the human Upf1 gene product that is involved in non- sense-mediated mRNA decay. RNA. 2000;6 (9):1226-35.
  54. Ohnishi T, Yamashita A, Kashima I, Schell T, Anders KR, Grimson A, et al. Phosphorylation of hUPF1 induces forma- tion of mRNA surveillance complexes con- taining hSMG-5 and hSMG-7. Mol Cell. 2003;12(5):1187-200.
  55. Singh G, Lykke-Andersen J. New insights into the formation of active nonsense-medi- ated decay complexes. Trends Biochem Sci. 2003;28(9):464-6.
  56. Behm-Ansmant I, Kashima I, Rehwinkel J, Sauliere J, Wittkopp N, Izaurralde E. mRNA quality control: an ancient machinery recog- nizes and degrades mRNAs with nonsense codons. FEBS Lett. 2007;581(15):2845-53.
  57. Hwang J, Sato H, Tang Y, Matsuda D, Maquat LE. UPF1 association with the cap- binding protein, CBP80, promotes non- sense-mediated mRNA decay at two distinct steps. Mol Cell. 2010;39(3):396-409.
  58. Song H, Mugnier P, Das AK, Webb HM, Evans DR, Tuite MF, et al. The crystal struc- ture of human eukaryotic release factor eRF1--mechanism of stop codon recognition and peptidyl-tRNA hydrolysis. Cell. 2000; 100(3):311-21.
  59. Frolova L, Le Goff X, Zhouravleva G, Davydova E, Philippe M, Kisselev L. Eukaryotic polypeptide chain release factor eRF3 is an eRF1-and ribosome-dependent guanosine triphosphatase. RNA. 1996;2(4): 334-41.
  60. Eberle AB, Stalder L, Mathys H, Orozco RZ, Muhlemann O. Posttranscriptional gene reg- ulation by spatial rearrangement of the 3' untranslated region. PLoS Biol. 2008;6(4): e92.
  61. Singh G, Rebbapragada I, Lykke-Andersen J. A competition between stimulators and antagonists of Upf complex recruitment governs human nonsense-mediated mRNA decay. PLoS Biol. 2008;6(4):e111.
  62. Kashima I, Yamashita A, Izumi N, Kataoka N, Morishita R, Hoshino S, et al. Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-medi- ated mRNA decay. Genes Dev. 2006;20(3):355-67.
  63. Silva AL, Ribeiro P, Inacio A, Liebhaber SA, Romao L. Proximity of the poly(A)-binding protein to a premature termination codon inhibits mammalian nonsense-mediated mRNA decay. RNA. 2008;14(3):563-76.
  64. Kashima I, Jonas S, Jayachandran U, Buchwald G, Conti E, Lupas AN, et al. SMG6 interacts with the exon junction com- plex via two conserved EJC-binding motifs (EBMs) required for nonsense-mediated mRNA decay. Genes Dev. 2010;24(21):2440- 50.
  65. Eberle AB, Lykke-Andersen S, Muhlemann O, Jensen TH. SMG6 promotes endonucle- olytic cleavage of nonsense mRNA in human cells. Nat Struct Mol Biol. 2009;16(1): 49-55.
  66. Huisman TH. The structure and function of normal and abnormal haemoglobins. Baillieres Clin Haematol. 1993;6(1):1-30.
  67. Le Hir H, Izaurralde E, Maquat LE, Moore MJ. The spliceosome deposits multiple pro- teins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J. 2000;19(24): 6860-9.
  68. Le Hir H, Moore MJ, Maquat LE. Pre-mRNA splicing alters mRNP composition: evidence for stable association of proteins at exon- exon junctions. Genes Dev. 2000;14(9):1098- 108.
  69. Zhang J, Sun X, Qian Y, Maquat LE. Intron function in the nonsense-mediated decay of beta-globin mRNA: indications that pre- mRNA splicing in the nucleus can influence mRNA translation in the cytoplasm. RNA. 1998;4(7):801-15.
  70. Romao L, Inacio A, Santos S, Avila M, Faustino P, Pacheco P, et al. Nonsense muta- tions in the human beta-globin gene lead to unexpected levels of cytoplasmic mRNA accumulation. Blood. 2000;96(8):2895-901.
  71. Baserga SJ, Benz EJ Jr. Nonsense mutations in the human beta-globin gene affect mRNA metabolism. Proc Natl Acad Sci USA. 1988;85(7):2056-60.
  72. Divoky V, Gu LH, Indrak K, Mocikova K, Zarnovicanova M, Huisman TH. A new beta zero-thalassaemia nonsense mutation (codon 112, T-->A) not associated with a dominant type of thalassaemia in the het- erozygote. Br J Haematol. 1993;83(3):523-4.
  73. Hall GW, Thein S. Nonsense codon muta- tions in the terminal exon of the beta-globin gene are not associated with a reduction in beta-mRNA accumulation: a mechanism for the phenotype of dominant beta-tha- lassemia. Blood. 1994;83(8):2031-7.
  74. Neu-Yilik G, Gehring NH, Thermann R, Frede U, Hentze MW, Kulozik AE. Splicing and 3' end formation in the definition of nonsense-mediated decay-competent human beta-globin mRNPs. EMBO J. 2001;20(3):532-40.
  75. Zhang J, Sun X, Qian Y, LaDuca JP, Maquat LE. At least one intron is required for the nonsense-mediated decay of triosephos- phate isomerase mRNA: a possible link between nuclear splicing and cytoplasmic translation. Mol Cell Biol. 1998;18(9):5272- 83.
  76. Sun X, Maquat LE. mRNA surveillance in mammalian cells: the relationship between introns and translation termination. RNA. 2000;6(1):1-8.
  77. Ruiz-Echevarria MJ, Gonzalez CI, Peltz SW. Identifying the right stop: determining how the surveillance complex recognizes and degrades an aberrant mRNA. EMBO J. 1998;17(2):575-89.
  78. Maquat LE, Carmichael GG. Quality control of mRNA function. Cell. 2001;104(2):173-6.
  79. Silva AL, Pereira FJ, Morgado A, Kong J, Martins R, Faustino P, et al. The canonical UPF1-dependent nonsense-mediated mRNA decay is inhibited in transcripts carrying a short open reading frame independent of sequence context. RNA. 2006;12(12):2160- 70.
  80. Zhang J, Maquat LE. Evidence that transla- tion reinitiation abrogates nonsense-mediat- ed mRNA decay in mammalian cells. EMBO J. 1997;16(4):826-33.
  81. Inacio A, Silva AL, Morgado A, Pereira FJ, Lavinha J, Romao L. Comment on 'Nonsense-mediated mRNA decay modu- lates clinical outcome of genetic disease'. Eur J Hum Genet. 2007 May;15(5):533-4; author reply 534.
  82. Danckwardt S, Neu-Yilik G, Thermann R, Frede U, Hentze MW, Kulozik AE. Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-medi- ated mRNA decay. Blood. 2002;99(5):1811- 6.
  83. Cao A, Gossens M, Pirastu M. Beta thalas- saemia mutations in Mediterranean popula- tions. Br J Haematol. 1989;71(3):309-12.
  84. Khajavi M, Inoue K, Lupski JR. Nonsense- mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet. 2006;14(10):1074-81.
  85. Kuzmiak HA, Maquat LE. Applying non- sense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol Med. 2006;12(7):306-16.

Cited by

Sorted by citations

See all 51

Metadata

Authors
Peixeiro, I., Silva, A. L., & Romao, L.
Venue
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Published
2011-02-28
Volume
96
Issue
6
Pages
905-913
ISSN
  • 0390-6078
  • 1592-8721
DOI
10.3324/haematol.2010.039206
Cited by
51
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review